HB 1095

  • Maryland House Bill
  • 2020 Regular Session
  • Introduced in House
  • Passed House Mar 15, 2020
  • Passed Senate Mar 17, 2020
  • Governor

Public Health - Prescription Drug Affordability Board and Fund

Votes


Actions


Feb 12, 2021

Senate

Overridden

Senate

Motion Special Order vote on veto until later today (Senator King) Adopted

House

Became law per Maryland Constitution, Chapter 28 of 2021

Feb 11, 2021

House

Overridden

Feb 08, 2021

House

Motion Special Order vote on veto until 2/11 (Delegate Luedtke) Adopted

Jan 13, 2021

House

Motion Special Order vote on veto until 2/8 (Delegate Luedtke) Adopted

May 07, 2020

Office of the Governor

Vetoed by the Governor (Policy)

Mar 18, 2020

House

Returned Passed

Mar 17, 2020

Senate

Third Reading Passed

Senate

Favorable Report by Finance

Senate

Favorable Adopted Second Reading Passed

Mar 15, 2020

House

Third Reading Passed

Senate

Referred Finance

Mar 14, 2020

House

Second Reading Passed with Amendments

House

Favorable with Amendments {

House

Favorable with Amendments Report by Health and Government Operations

Feb 10, 2020

House

Hearing 3/05 at 1:00 p.m.

Feb 06, 2020

House

First Reading Health and Government Operations

Bill Text

Bill Text Versions Format
First - Public Health - Prescription Drug Affordability Board and Fund PDF
Third - Public Health - Prescription Drug Affordability Board and Fund PDF
Chapter - Public Health - Prescription Drug Affordability Board and Fund PDF

Related Documents

Document Format
Fiscal and Policy Note (Revised) PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Maryland General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.